Lung Cancer
Conditions
Interventions
Experimental group:Single port thoracoscopic segmentectomy
Control group:Multi-hole thoracoscopic segmentectomy
Sponsors
Shanghai Pulmonary Hospital
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged >=18 years old; 2. Non-small cell lung cancer (NSCLC) diagnosed by histological biopsy. 3. Patients who showed stage IA by needle biopsy, chest CT, and PET-CT with imaging findings of ground glass nodules with a solid component =12 weeks; 5. According to the Eastern United States Oncology Group's physical status score (ECOG PS score) 0-1 points; 6. Have sufficient organ and bone marrow function.
Exclusion criteria
Exclusion criteria: 1. Active, known or suspected autoimmune diseases; 2. A known history of primary immunodeficiency; 3. A known history of allogeneic organ transplantation and allogeneic hematopoietic stem cell transplantation; 4. Female patients who are pregnant or breastfeeding; 5. Acute or chronic active hepatitis B or C infection without treatment. In the case of patients receiving antiviral therapy, the doctor will judge whether they are eligible for enrollment according to the individual conditions of the patient while monitoring the virus copy number; 6. Uncontrolled concurrent diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score;Conversion rate;complication; | — |
Countries
China
Contacts
Public ContactHu Xuefei
Shanghai Pulmonary Hospital
Outcome results
None listed